November 26, 2014 | The venture capital arm of Chinese pharmaceutical company Fosun Pharma, the Hermed Fund, is seeking out a strategic investment partner in Israel and are considering investments in Israeli companies. The pharmaceutical daughter company of Chinese giant Fosun, worth approx. $8 billion, acquired Israeli startup Alma Lasers for $240 million and made investments in Check-Cap and Tyto Care. In addition, the Hermed Fund is considering partnering with a local fund or investment entity that will act as its representative within Israel. Fosun focuses the majority of its efforts on developing generic drugs, biosimilars, diagnosis mechanisms and health services.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments